CAR T-Cell Therapy in Multiple Myeloma and Quality of Life

Video

A look at the quality of life of patients with multiple myeloma who received CAR T-cell therapy.

Recent Videos
The trispecific antibody JNJ-5322 demonstrated superior efficacy vs approved agents in multiple myeloma in results shared at the 2025 EHA Congress.
Related Content